(0.17%) 5 108.66 points
(0.30%) 38 354 points
(0.00%) 15 928 points
(-0.39%) $83.52
(2.34%) $1.968
(-0.39%) $2 338.10
(-0.23%) $27.47
(2.71%) $947.05
(0.01%) $0.935
(-0.06%) $11.02
(-0.20%) $0.799
(1.90%) $93.62
Live Chart Being Loaded With Signals
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents...
Stats | |
---|---|
本日の出来高 | 553.00 |
平均出来高 | 4 691.00 |
時価総額 | 17.93B |
EPS | €0 ( 2024-04-17 ) |
次の収益日 | ( €0 ) 2024-07-18 |
Last Dividend | €1.430 ( 2023-03-30 ) |
Next Dividend | €0 ( N/A ) |
P/E | 105.09 |
ATR14 | €0.772 (0.34%) |
ボリューム 相関
Sartorius AG 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Sartorius AG 相関 - 通貨/商品
Sartorius AG 財務諸表
Annual | 2023 |
収益: | €3.40B |
総利益: | €1.57B (46.15 %) |
EPS: | €4.95 |
FY | 2023 |
収益: | €3.40B |
総利益: | €1.57B (46.15 %) |
EPS: | €4.95 |
FY | 2022 |
収益: | €4.17B |
総利益: | €2.20B (52.61 %) |
EPS: | €13.35 |
FY | 2021 |
収益: | €3.45B |
総利益: | €1.84B (53.31 %) |
EPS: | €4.66 |
Financial Reports:
No articles found.
Sartorius AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€1.430 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.0600 | 2000-06-22 |
Last Dividend | €1.430 | 2023-03-30 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 25 | -- |
Total Paid Out | €8.48 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.15 | -- |
Div. Sustainability Score | 9.59 | |
Div.Growth Potential Score | 6.39 | |
Div. Directional Score | 7.99 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSG.DE | Ex Dividend Knight | 2023-06-29 | Annually | 0 | 0.00% | |
BIJ.DE | Ex Dividend Knight | 2023-06-21 | Sporadic | 0 | 0.00% | |
IE2A.F | Ex Dividend Junior | 2023-05-02 | Sporadic | 0 | 0.00% | |
SOW.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
CRZK.DE | Ex Dividend Junior | 2023-07-17 | Annually | 0 | 0.00% | |
LLD.DE | Ex Dividend Junior | 2023-08-03 | Annually | 0 | 0.00% | |
1U1.DE | Ex Dividend Junior | 2023-05-17 | Annually | 0 | 0.00% | |
UWS.DE | Ex Dividend Knight | 2023-09-07 | Quarterly | 0 | 0.00% | |
EIN3.DE | Ex Dividend Knight | 2023-06-26 | Annually | 0 | 0.00% | |
NOVC.DE | Ex Dividend Junior | 2023-08-18 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0739 | 1.500 | 8.52 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0230 | 1.200 | 9.23 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.111 | 1.500 | 9.88 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.000409 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 2.02 | 0.800 | 4.88 | 3.90 | [1 - 3] |
quickRatioTTM | 1.193 | 0.800 | 7.69 | 6.15 | [0.8 - 2.5] |
cashRatioTTM | 0.803 | 1.500 | 6.65 | 9.97 | [0.2 - 2] |
debtRatioTTM | 0.479 | -1.500 | 2.02 | -3.04 | [0 - 0.6] |
interestCoverageTTM | 2.48 | 1.000 | -0.194 | -0.194 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.05 | 2.00 | 6.65 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.973 | 2.00 | 9.01 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.904 | -1.500 | 2.39 | -3.58 | [0 - 2.5] |
grossProfitMarginTTM | 0.451 | 1.000 | 5.81 | 5.81 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.150 | 1.000 | 8.99 | 8.99 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.135 | 1.000 | -0.360 | -0.360 | [0.2 - 2] |
assetTurnoverTTM | 0.312 | 0.800 | -1.256 | -1.005 | [0.5 - 2] |
Total Score | 9.59 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 63.47 | 1.000 | 3.69 | 0 | [1 - 100] |
returnOnEquityTTM | 0.111 | 2.50 | 9.92 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.973 | 2.00 | 9.34 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.322 | 1.500 | 1.960 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.05 | 2.00 | 6.65 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.000409 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 27.29 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.208 | 1.000 | 7.31 | 0 | [0.1 - 0.5] |
Total Score | 6.39 |
Sartorius AG
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。